Should you tolerate odd decisions by directors?

New drug approvals ease fears of a regulatory slowdown

---

Most popular UK equity fund

---

Shrinkflation sparks competition

---

ASDA sales suggest supermarket strength

---

UK Stocks - Free Cash Flow Dividend Cover

---

Highest Yielding UK Stocks

---

Jurassic potential for Frontier

---

Why BAE Systems’ share price slump might be over

---

Zotefoams is one of our favourite chemical stocks

---

AorTech shares soar on financial update

---

Victoria gets Cameroon well boost

---

Yolo makes bold claim

---

Toy group to show its Character

---

Market giants

---

Are insurers braced for another change to compensation payments?

What an income fund shake-up means for you

Get in quick with this unsung small cap hero

---

Shining a light on Midwich’s bright future

---

Cineworld is ‘lone shining star’ in leisure sector

---

Bluejay Mining has ‘exceptional deposit’ claims broker

---

Is Capital Drilling now a takeover target?

New stars of the investment trust space

Get ready for changes to FTSE 100 and 250

---

Clouds gather as autumn political risks loom

---

Rathbones in merger talks

---

The DIY Investor competition winners

---

Zinc trading at a 10-year high

---

Standard Life Aberdeen looks set to bring returns

How savers have missed out on £94bn of returns

---

The 10 biggest investment mistakes

Micro Focus a total returns rare breed

Ladbrokes Coral machine dilemma

---

Can Restaurant Group bounce back?

---

Bunzl anticipates growth